Concord Drugs Ltd manufactures licensed drugs based on approved formulationsProduct Portfolio: a) Pharmaceutical Ready to fill Pellets b) Multiple Unit Pellet System (MUPS) c) Tissue Bio Adhesive d) Injectables (Small Volume Parenterals) e) Oral Solid Dosages (Tablets & Capsules) f) Liquid Orals (Syrups & Suspensions) g) Dry Syrup (Powder)
NTPC's Chairman & MD met with the Chief Minister to discuss a major investment. NTPC is prepared to inject Rs. 80,000 Crore into new solar and wind power projects in the state, targeting 6,700 MW of floating solar capacity. The Chief Minister assured full government cooperation. This strategic investment highlights...
Aarthi Consultants Pvt. Ltd has confirmed that Concord Drugs Limited’s securities received for dematerialization between April and June 2025 were processed within 15 days. The certificates were mutilated and cancelled, and the depository’s name was updated as the registered owner in the company’s records. This ensures smooth electronic trading and...
Concord Drugs Limited has announced a board meeting that approved increasing its authorized share capital from Rs. 11 Cr to Rs. 15.5 Cr, expanding equity shares from 1.1 crore to 1.55 crore shares of Rs. 10 each. This change will be reflected in the Memorandum of Association, subject to shareholder...
Concord Drugs Limited has submitted its Annual Secretarial Compliance Report for the year ended March 31, 2025, prepared by PSK & Associates, confirming adherence to applicable SEBI regulations and corporate governance practices. The report notes a minor delay in filing under Regulation 76 of Depositories and Participants Regulations, with management...
Concord Drugs Limited has announced a board meeting to discuss the company’s financial results for the quarter and half-year ending March 2025. The Registrar and Share Transfer Agent, Aarthi Consultants, confirmed compliance with dematerialization regulations, indicating that securities have been duly dematerialized and listed accordingly. The update reflects the company's...
